The biggest and most important Psychedelic Medicine Conference in the Southern Hemisphere
International Summit on Psychedelic Therapies
for Mental Illness
2 Day Introductory Workshop program in Psychedelic Therapies
+ 2 Day Public Summit
17 – 20 November 2021 (Online Event)
Mind Medicine Australia will hold a two-day International Summit on Psychedelic Therapies for Mental Illness online in November 2021, bringing together clinicians, scientists, academics, mental and public health professionals, philanthropists, investors, Government, law and policy leaders, business, industry, consumers and other interested stakeholders.
The event will also feature a two-day pre-Summit introductory workshop program (17-18 November) for anyone with an interest in the topic and who is considering further development of their current therapeutic skills or who are eager to gain a detailed understanding of psychedelic-assisted psychotherapy for the treatment of mental illness.
The Summit will feature a rich program with a mixture of international and national keynotes, workshops, hot spots and panel conversations.
We already have a range of leading international speakers committed for the 2-day summit including:
- Professor David Nutt (UK) Head of Neuropsychopharmacology at Imperial College London and Chief Research Officer at Awakn Life Sciences,
- Dr Gabor Maté (Canada) renowned trauma and addiction physician,
- Professor Roland Griffiths (USA) Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine,
- Dr Bill Richards (USA) world-leading therapist trainer and psychologist at the Johns Hopkins School of Medicine,
- Dr Ben Sessa (UK) Chief Medical Officer at Awakn Life Sciences, Psychiatrist, Researcher and Writer,
- Professor Robin Carhart-Harris (UK) Ralph Metzner Distinguished Professor, Weill Institute for Neurosciences and University of California San Francisco,
- Johann Hari (UK) Journalist and Bestselling Author,
- Francoise Bourzat (USA) Psychedelic Guide Trainer and Author,
- Wade Davis (Canada) anthropologist, ethnobotanist and Explorer in Residence at the National Geographic Society,
- Dr Rami Batal (USA) Chief Executive Officer – Universal Ibogaine,
- Dr Alberto Villoldo (USA) medical anthropologist and author,
- Dr Lynn Marie Morski (USA) President of the Psychedelic Medicine Association,
- Professor Matthew Johnson (USA) Susan Hill Ward Professor of Psychedelics at Johns Hopkins University School of Medicine,
- Dr Reid Robinson (USA) Psychiatrist, Researcher & Chief Medical Officer, Novamind,
- Dr Jennifer Mitchell (USA) Professor in the Departments of Neurology and Psychiatry and Behavioral Sciences at UCSF,
- Patrycja Slawuta (USA) Researcher & Psychologist,
- Admiral Chris Barrie AC (AUS) former Head of the Australian Defence Force and Strategic Leadership Consultant,
- Professor Arthur Christopoulos (AUS) Professor of Analytical Pharmacology and Molecular Neuropsychopharmacologist at Monash University,
- Ronan Levy (Canada) Co-founder and the Executive Chairman of Field Trip Health,
- Srinivas Rao (USA) co-founder & Chief Scientific Officer, atai Life Sciences,
- Kelsey Ramsden (Canada) Co-Founder, CEO & President of Mindcure,
- Dr Lyle Oberg (Canada) Co-Founder and CEO at MYND,
- Michael Winlo (AUS) Managing Director, Emyria,
- Joseph Araujo (Canada) Co-Founder and Chief Scientific Officer of Mindset Pharma and the CEO and President of InterVivo Solutions,
- John Skerritt (AUS) Deputy Secretary, Health Products Regulation Group – TGA,
- Dr Simon Longstaff (AUS) Executive Director of The Ethics Centre,
- Dr Eli Kotler (AUS) Psychiatrist and Director of Medicine at Malvern Private Hospital,
- Vince Polito (AUS) Senior Research Fellow in the Department of Cognitive Science at Macquarie University in Sydney,
- Tania de Jong AM (AUS) Founder Creative Universe, Creativity Australia, Creative Innovation Global and Mind Medicine Australia,
- Peter Hunt AM (AUS) Investment Banker & engaged Philanthropist; Founder Women’s Community Shelters and Mind Medicine Australia…
and more to be announced.
All delegates will receive the recordings of all key sessions and the presentations from keynote talks.